In this issue:
Comparison of clinical trial eligible and ineligible patients
The microbiome in psoriasis
Calcipotriol/betamethasone aerosol foam for plaque psoriasis
Methotrexate and liver cirrhosis in psoriasis patients with HBV/HCV
T-cell–mediated immune response during tofacitinib treatment
Biologic treatment of recalcitrant paediatric psoriasis
Mental health outcomes after biologic vs oral therapies
Paediatric patients with psoriasis and psychiatric disorders
Guselkumab in generalised pustular psoriasis and erythrodermic psoriasis
Clinical response to methotrexate in Asian patients
Please login below to download this issue (PDF)